The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study
Torsten Dahlén(Karolinska University Hospital), Fredrik Nyberg(National Academy of Medicine), Ulla Olsson‐Strömberg(Uppsala University Hospital), Anna Lübking(Skåne University Hospital), Anders Själander(Umeå University), Magnus Gisslén(Public Health Agency of Sweden), Arta Dreimane(Linköping University Hospital), Hjalmar Flygt(Uppsala University Hospital), Susannah Leach(Sahlgrenska University Hospital), Huiqi Li(University of Gothenburg), Leif Stenke(Karolinska University Hospital), Lovisa Wennström(Sahlgrenska University Hospital), Martin Höglund(Uppsala University)
Cited by 5
Related Papers
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
|Blood|2013|632
Interstitial Lung Disease in Japanese Patients with Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2008|488
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
|PLoS ONE|2014|167